Vivendi

Announcement 8 March 2021

Company: Vivendi
Situation: Announced distribution of UMG's share capital
Method: Package method 
Date: 27 September 2021
Remark: Vivendi has announced on 13 February 2021 their intention to distribute 60% of UMG's share capital and its listing by the end of the year. If this distribution will take place the derivatives will be adjusted in accordance with the package method. 

BNP Paribas

Announcement 23 February 2021

Company: BNP Paribas
Situation: Announced dividend payment of EUR 1.57
Method: No adjustment
Date: TBA
Remark: BNP Paribas has announced a dividend of 1.11 euro per share and a possible additional restitution of the remaining 29% of 2020 net income after the end of September 2021. The full amount of of these amounts combined is considered as ordinary. If this additional restitution takes place no adjustment will be made for the derivatives.

Randstad

Announcement 9 February 2021

Company: Randstad
Situation: Announced dividend payment of EUR 3.24
Method: No adjustment
Date: 25 March 2021 and 24 September 2021
Remark: Randstad has announced their intention to pay a dividend of EUR 3.24. The full amount of EUR 3.24 is considered as ordinary. If this takes place no adjustment will be made for the derivatives.

Tele2

Announcement 22 April 2021

Company: Tele2
Situation: Announced an Extra ordinary dividend payment of SEK 3.00
Method: Ratio method 
Date: TBA
Remark: The Tele2 Board proposes an extraordinary dividend of SEK 3.00 per share subject to approval of the EGM Juni 2021.

Bawag Group

Announcement 9 February 2021

Company: Bawag Group
Situation: Special dividend of EUR 88 million
Method: Ratio method
Date: TBA
Remark: The Managing Board has proposed a special dividend of € 88 million for 2020. Including this special dividend the remaining € 420 million dividends (or € 4.72 per share) will be proposed for distribution to the Annual General Meeting on 27 August 2021 (dividend payout early October 2021).

Disclaimer

The information on this page is solely intended as information. Although this information is issued in good faith, no representation or warranty, expressed or implied, is or will be made. No responsibility or liability is or will be accepted by Euronext or by any of its officers, employees, or agents in relation to the accuracy or completeness of this information. Any such liability is expressly disclaimed.

Contact Information

Euronext - EMS Derivatives Corporate Actions

Corporate Action Team
PO Box 19163
1000 GD Amsterdam
The Netherlands

+31 20 721 9588
corporateactionsteam@euronext.com